HMGB1 and plasma cell myeloma: This role extends to chemotherapy, as evidenced in multiple myeloma, where HMGB1 knockdown increased DNA damage markers (γH2A.X) and decreased the key homologous recombination protein Rad51 as well as pro-survival autophagy following dexamethasone treatment [36].